tm
Seeing Is Believing
tm
Seeing Is Believing
Chemomab Therapeutics Ltd DRC's activity chart (see below) currently has 7 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 106.86 days.
Most recent stock forecast was given by from OPPENHEIMER on 27-Aug-2025. First documented stock forecast 11-Mar-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Jul-2024
$25
$23.41 (1472.33%)
$10
1 years 16 days ago
(27-Aug-2025)
2/5 (40%)
$21.52 (618.39%)
86
Buy Since 13-May-2024
$28
$26.22 (1473.03%)
$16
1 years 6 months 23 days ago
(20-Feb-2025)
0/2 (0%)
$20.92 (295.48%)
Hold
$7
3 years 3 months 5 days ago
(07-Jun-2023)
0/4 (0%)
$5.34 (321.69%)
Buy Since 11-Mar-2019
4 years 6 months 2 days ago
(10-Mar-2022)
1/2 (50%)
$154.24 (151.57%)
450
Buy Since 08-Dec-2021
$120
4 years 9 months 4 days ago
(08-Dec-2021)
0/1 (0%)
$88.44 (280.23%)
What is CMMB (Chemomab Therapeutics Ltd DRC) average time for price targets to be met?
Which analyst most recently updated their price target on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst has the current lower performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?
Which analyst has the most public recommendations on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most bullish on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most reserved on CMMB (Chemomab Therapeutics Ltd DRC)?
